Zaloguj Zarejestruj się zadarmo

Adaptimmune Therapeutics Plc organizacji Pracownicy

Jaka jest wartość Pracownicy organizacji Adaptimmune Therapeutics Plc?

Wartość Pracownicy organizacji Adaptimmune Therapeutics Plc to 477

Jaka jest definicja Pracownicy?

Pracownicy (Employees) to ilość pracowników, która może mieć postać stawki godzinowej, akordowej lub rocznej, w zależności od rodzaju wykonywanej pracy przez pracownika lub branży, w której pracuje.

Employment is a relationship between two parties, usually based on a contract where work is paid for, where one party, which may be a corporation, for profit, not-for-profit organization, co-operative or other entity is the employer and the other is the employee.

Employees in some fields or sectors may receive gratuities, bonus payment or stock options. In some types of employment, employees may receive benefits in addition to payment. Benefits can include health insurance, housing, disability insurance or use of a gym. Employment is typically governed by employment laws or regulations or legal contracts.

Pracownicy firm w Health Care sektor na NASDAQ w porównaniu do Adaptimmune Therapeutics Plc

Czym się zajmuję organizacja Adaptimmune Therapeutics Plc?

adaptimmune llc is a multinational, clinical-stage biopharmaceutical company focused on developing novel immunotherapies using its proprietary t-cell receptor platform that has the potential to transform the treatment of cancer. established in 2008, the company has grown from being privately held to one of the most successful biopharmaceutical initial public offerings (ipo) in 2015. with u.s. operations based in philadelphia, pa, adaptimmune is a company founded on strong science that has led to a robust pipeline of immuno-oncology product candidates, a growing research & development platform and ongoing plans for expansion. for more information about adaptimmune, please visit www.adaptimmune.com. if interested in joining our fast growing team, click on the careers tab of this page.

Firmy z pracownicy podobne do Adaptimmune Therapeutics Plc